Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Casopitant for Prevention of Cisplatin-Induced Nausea and Vomiting
NCT00891761Phase 3Withdrawn
- Sponsor
- GSK
- Start
- Sep 2009
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of casopitant in chemotherapy-induced nausea and vomiting (CINV), sponsored by GSK. Planned start Sep 2009; status: withdrawn.
02
Drugs
casopitant
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT00891761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00891761.